The session will describe the results of completed trials of investigational psychedelic medications in the treatment to alcohol use disorder. Evidence for safety and efficacy will be evaluated, and possible mechanisms of action will be discussed based on currently available data. The prevention will also discuss possible next steps toward clinical use and safe and equitable dissemination of new treatments should they become available for clinical use.
Learning Objectives:
Learners will be able to:
Describe the results and limitations of completed trials of psychedelics in the treatment of alcohol use disorder, including evidence regarding efficacy, safety, and mechanisms of action.
